1 |
Destructive effect of iron overload in brain tissue of albino rats: Ameliorative role of silver immobilized organo-modified casein nanocomposite as co-treating agent with Deferasirox.
62
|
Adel RM...Amer AS
|
34052583 |
2021 |
2 |
Network pharmacology-based identification of the key mechanism of quercetin acting on hemochromatosis.
62
|
Ding H...Feng J
|
33960370 |
2021 |
3 |
Hfe Gene Knock-Out in a Mouse Model of Hereditary Hemochromatosis Affects Bodily Iron Isotope Compositions.
62
|
Albalat E...Loreal O
|
34722560 |
2021 |
4 |
[Aceruloplasminemia, a rare condition not to be overlooked].
62
|
Lobbes H...Durupt S
|
32682623 |
2020 |
5 |
Strain Analysis Using Feature-Tracking CMR to Detect LV Systolic Dysfunction in Myocardial Iron Overload Disease.
62
|
Tahir E...Schoennagel BP
|
32739373 |
2020 |
6 |
Hereditary hemochromatosis promotes colitis and colon cancer and causes bacterial dysbiosis in mice.
62
|
Sivaprakasam S...Ganapathy V
|
32955078 |
2020 |
7 |
A Novel Star Like Eight-Arm Polyethylene Glycol-Deferoxamine Conjugate for Iron Overload Therapy.
62
|
Yu B...Liu H
|
32272723 |
2020 |
8 |
Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.
62
|
Wortham AM...Enns CA
|
32054685 |
2020 |
9 |
Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer.
62
|
Bhutia YD...Ganapathy V
|
32373202 |
2020 |
10 |
HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case.
62
|
Zhang W...Jia J
|
32153640 |
2020 |
11 |
Facile Access to Fe(III)-Complexing Cyclic Hydroxamic Acids in a Three-Component Format.
62
|
Chupakhin E...Krasavin M
|
30823493 |
2019 |
12 |
Deferoxamine-induced high expression of TfR1 and DMT1 enhanced iron uptake in triple-negative breast cancer cells by activating IL-6/PI3K/AKT pathway.
62
|
Chen C...Xu LX
|
31213851 |
2019 |
13 |
[Body iron accumulation in obesity, diabetes and its complications, and the possibility of therapeutic application by iron regulation].
62
|
Horinouchi Y...Tamaki T
|
31787683 |
2019 |
14 |
Quantification of liver iron overload disease with laser ablation inductively coupled plasma mass spectrometry.
62
|
Kim P...Weiskirchen R
|
30514216 |
2018 |
15 |
Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects.
62
|
Loreal O...Brissot P
|
30486249 |
2018 |
16 |
Iron chelation inhibits cancer cell growth and modulates global histone methylation status in colorectal cancer.
62
|
Cao LL...Jia M
|
29951879 |
2018 |
17 |
A novel, nontoxic iron chelator, super-polyphenol, effectively induces apoptosis in human cancer cell lines.
62
|
Ohara T...Matsukawa A
|
30214682 |
2018 |
18 |
Cyclic Hydroxamic Acid Analogues of Bacterial Siderophores as Iron-Complexing Agents prepared through the Castagnoli-Cushman Reaction of Unprotected Oximes.
62
|
Bakulina O...Krasavin M
|
29072340 |
2017 |
19 |
Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.
62
|
Loza-Rosas SA...Tinoco AD
|
28644630 |
2017 |
20 |
[Expression and Significance of HIF-1α in Erythropoiesis of Secondary Iron Overload Disease after Irradiation Damage].
62
|
Xing Y...He XY
|
28641612 |
2017 |
21 |
Evaluation of iron chelating and antioxidant potential of Epilobium hirsutum for the management of iron overload disease.
62
|
Sheikh NA...Tirgar PR
|
28320102 |
2017 |
22 |
Iron overload patients with unknown etiology from national survey in Japan.
62
|
Ikuta K...Kohgo Y
|
27848180 |
2017 |
23 |
Left atrial active contractile function parameters assessed by cardiac MR are sensitive to myocardial iron.
62
|
Wehbe MS...Schoennagel BP
|
27459111 |
2017 |
24 |
Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68.
62
|
Cusnir R...Ma MT
|
28075350 |
2017 |
25 |
Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis.
62
|
Pellegrino RM...Roetto A
|
28540293 |
2017 |
26 |
Investigation into Iron Chelating and Antioxidant Potential of Melilotus officinalis in Iron Dextran Induced Iron Overloaded Sprague Dawley Rat Model.
62
|
Sheikh NA...Tirgar PR
|
27626608 |
2016 |
27 |
Melanin nanoparticles as an endogenous agent for efficient iron overload therapy.
62
|
Yan J...Yang M
|
32263725 |
2016 |
28 |
Increased Retinal Expression of the Pro-Angiogenic Receptor GPR91 via BMP6 in a Mouse Model of Juvenile Hemochromatosis.
62
|
Arjunan P...Ganapathy V
|
27046124 |
2016 |
29 |
HJV and HFE Play Distinct Roles in Regulating Hepcidin.
62
|
Wu Q...Wang F
|
25608116 |
2015 |
30 |
Redox properties and activity of iron-citrate complexes: evidence for redox cycling.
62
|
Adam FI...Koppenol WH
|
25654270 |
2015 |
31 |
Yersinia enterocolitica Septicemia After Chitterling Ingestion in a Pediatric Patient With Iron Overload Disease: A Case Report.
62
|
Moon TD...Sheram ML
|
27335968 |
2015 |
32 |
Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus.
62
|
Arezes J...Bulut Y
|
25590758 |
2015 |
33 |
Iron clad: iron homeostasis and the diagnosis of hereditary iron overload.
62
|
Heeney MM
|
25696856 |
2014 |
34 |
Iron, oxidative stress, and redox signaling in the cardiovascular system.
62
|
Gudjoncik A...Rochette L
|
24888568 |
2014 |
35 |
Deletion of hemojuvelin, an iron-regulatory protein, in mice results in abnormal angiogenesis and vasculogenesis in retina along with reactive gliosis.
62
|
Tawfik A...Ganapathy V
|
24812553 |
2014 |
36 |
The role of hepatic transferrin receptor 2 in the regulation of iron homeostasis in the body.
62
|
Worthen CA...Enns CA
|
24639653 |
2014 |
37 |
[The effect of exogenous antioxidants on the antioxidant status of erythrocytes and hepcidin content in blood of patients with disorders of iron metabolism regulation].
62
|
Shcherbinina SP...Ataullakhanov FI
|
24511683 |
2013 |
38 |
[Iron quantification in iron overload disease using MRI].
62
|
Schonnagel BP...Yamamura J
|
23450372 |
2013 |
39 |
[Hemochromatosis: one form of iron-overload diseases].
62
|
Szalay F
|
23853349 |
2013 |
40 |
N-linked glycosylation is required for transferrin-induced stabilization of transferrin receptor 2, but not for transferrin binding or trafficking to the cell surface.
62
|
Zhao N...Enns CA
|
23556518 |
2013 |
41 |
Hereditary hemochromatosis.
62
|
Crownover BK...Covey CJ
|
23418762 |
2013 |
42 |
The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action.
62
|
Lui GY...Richardson DR
|
23074173 |
2013 |
43 |
Absorption of manganese and iron in a mouse model of hemochromatosis.
62
|
Kim J...Wessling-Resnick M
|
23705020 |
2013 |
44 |
Effects of quercetin on hemoglobin-dependent redox reactions: relationship to iron-overload rat liver injury.
62
|
Lu NH...Peng YY
|
24215437 |
2013 |
45 |
Hereditary hemochromatosis and transferrin receptor 2.
62
|
Chen J...Enns CA
|
21864651 |
2012 |
46 |
Screening for hereditary haemochromatosis.
62
|
Nadakkavukaran IM...Olynyk JK
|
22198253 |
2012 |
47 |
Iron chelators for the treatment of cancer.
62
|
Yu Y...Richardson DR
|
22455580 |
2012 |
48 |
Polarized distribution of heme transporters in retinal pigment epithelium and their regulation in the iron-overload disease hemochromatosis.
62
|
Gnana-Prakasam JP...Ganapathy V
|
22058337 |
2011 |
49 |
Conditional disruption of mouse HFE2 gene: maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin.
62
|
Gkouvatsos K...Pantopoulos K
|
21748766 |
2011 |
50 |
Hepcidin and ferroportin: the new players in iron metabolism.
62
|
De Domenico I...Kaplan J
|
21901657 |
2011 |